key: cord-0820586-v9mzjygm
authors: Dhwaj Ashwlayan, Vrish; Antlash, Chanchal; Imran, Mohd.; Mohammed Basheeruddin Asdaq, Syed; Kanan Alshammari, Mohammed; Alomani, Marwa; alzahrani, Eman; Sharma, Divya; Tomar, Ritu; Abida
title: INSIGHTS INTO THE BIOLOGICAL IMPACT OF COVID-19 AND ITS VACCINES ON HUMAN HEALTH
date: 2022-02-12
journal: Saudi J Biol Sci
DOI: 10.1016/j.sjbs.2022.02.010
sha: 94b016bc8a3dfeb27665de72f1454b0428569901
doc_id: 820586
cord_uid: v9mzjygm

COVID-19 (coronavirus disease-2019) is a contagious illness that has been declared a global epidemic by the World Health Organization (WHO). The coronavirus causes diseases ranging in severity from the common cold to severe respiratory diseases and death. Coronaviruses primarily affect blood pressure by attaching to the angiotensin converting enzyme 2 (ACE 2) receptor. This virus has an impact on multiple organ systems, including the central nervous system, immune system, cardiovascular system, peripheral nervous system, gastrointestinal tract, endocrine system, urinary system, skin, and pregnancy. For the prevention of COVID-19, various vaccines such as viral-like particle vaccines, entire inactivated virus vaccines, viral vector vaccines, live attenuated virus vaccines, subunit vaccines, RNA vaccines, and DNA vaccines are now available. Some of the COVID-19 vaccines are reported to cause a variety of adverse effects that range from mild to severe in nature. SARS-CoV-2 replication is controlled by the RNA-Dependent RNA-Polymerase enzyme (RdRp). The availability of FDA-approved anti-RdRp drugs (Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir) as potent drugs against SARS-CoV-2 that tightly bind to its RdRp may aid in the treatment of patients and reduce the risk of the mysterious new form of COVID-19 viral infection. RdRp inhibitors, such as remdesivir (an anti-Ebola virus experimental drug) and favipiravir (an anti-influenza drug), inhibit RdRp and thus slow the progression of COVID-19 and associated clinical symptoms, as well as significantly shorten recovery time. Molnupiravir, an orally active RdRp inhibitor and noval broad spectrum antiviral agent, is an isopropyl pro-drug of EIDD-1931 for emergency use. Galidesivir's in vitro and in vivo activities are limited to RNA of human public health concern. Top seeds for antiviral treatments with high potential to combat the SARS-CoV-2 strain include guanosine derivatives (IDX-184), setrobuvir, and YAK. The goal of this review is to compile scattered information on available COVID-19 vaccines and other treatments for protecting the human body from their harmful effects and to provide options for making better choices in a timely manner.

In 2019 Dec, COVID-19 (a novel coronavirus disease) pestilence was accounted for in Wuhan, China, which is brought about by SARS -CoV-2 . Covid has a place with the Coronaviridae family. The genus of the virus is "corona" which means Crown, the crown-like projections appear on the surface of the virus. In the last part of 1960s, it was first separated from patients experiencing regular cold, named as B814 and imagined under an electron magnifying instrument (Mahalmani et al., 2020) . All CoVs (coronaviruses) have pleomorphic RNA typically consisting of crown-shape peplomers with 80-160 nM dimensions and 27 The sickness is passed on from one person to another by inward breath or contact with air droplets of infected person and the maturation time goes from two to fourteen days. The indications are generally pyrexia, sore throat, cough, shortness of breath, tiredness, restlessness and the rest. The sickness is not strong in many persons; in a few (generally old and individual having various disease symptoms), it might advance to wet lungs, pneumonia, and impairment of multiple body parts. Numerous individuals are symptomless. Basic lab discoveries incorporate usual/poor WBC's count with raised C-reactive protein. The computed tomographic chest examine is generally uncommon however in those without any manifestations otherwise moderate infection. Therapy is basically protective. The infection spreads quicker in comparison to 2 precursors SARS-CoV and MERS-CoV, however has lower fatality (Singhal, 2020) .

The objective of the study is to spread awareness about available COVID-19 Vaccines and other treatments for protecting the human body from their dangerous effects and to give option for selecting better choice timely.

Coronaviruses have positive-sense RNA, possess a broad and indiscriminate limit of natural host and influence various arrangements (Dhama et al., 2020) . Coronaviruses have spherical shape or pleomorphic, solitary stranded, wrapped RNA and shield with clavate form glycoprotein. Coronaviruses have 4 sub kinds, for example, α, β, γ, and δ Coronavirus . Coronavirus The E protein is the more perplexing and most little of the significant structural proteins. E protein takes a multifaceted part in the pathogenicity, assembly, and liberation of the virus.

Coronavirus's N protein has multifunction. Among a few activities, N protein takes a part in compound synthesis with the virus genome, facilitates M protein interaction required for virion construction, and increase virus transcription efficiency (Dhama et al., 2020) .

SARS-CoV2 has single strand RNA. SARS-CoV2 enters in human cells through attaching to ACE-2, which is mostly found in cardiovascular myocytes, lung alveolar cells, the vascular endothelium, and different cells. SARS-CoV2 is mainly circulated through inhalation of virus particle and passes into the respiratory system. Apart from this, the virus can stay on the surface for 24-72 hours, contingent upon the sort of surface, which facilitates fomite transmission (Bikdeli et al., 2020) . COVID-19 may only infect the lungs in most individuals because it is mostly a respiratory disorder (Prompetchara et al., 2020) .

Within the patient, the virus's life cycle is divided into five stages: attachment, penetration, biosynthesis, maturation, and release. Firstly, virus attaches to the receptor site in the host body, it is called attachment. By membrane fusion or endocytosis process, the virus enters the patient cells, it is called penetration. Then the virus releases its content in inner part of host cells, the RNA of virus invades into the nucleus for reproduction. The mRNA of virus is utilized to synthesize viral proteins; this process is called biosynthesis. After that, the new particles of virus have produced, it is called maturation. The functioning receptor for SARS-CoV has been recognized as ACE2. The spike for SARS-CoV-2 also bound to ACE2, it was determined in the structural and functional analysis. ACE2 was found in kidney, heart, lungs, ileum, and bladder in more amount. The lungs epithelial cells were extremely expressed by ACE2 (Yuki et al., 2020) . COVID-19 may be separated into 3 stages depending on the cells which are probably infected, which relate to various clinical phases of the illness.

When a patient inhales, the virus (SARS-CoV-2), it attaches to the epithelial cells in the nasal cavity and begins reproducing. SARS-CoV and SARS-CoV2 both has the same fundamental receptor which is ACE2. According to an in-vitro study, it was found that ciliated cells were more infected by SARS-CoV in the conducting airways. Nonetheless, this idea may require certain update, since small amount of ACE2 expression were showed by the single-cell RNA in conducting airway cells and no conspicuous cell type preference. The virus has limited multiplication of however a restricted innate immune response. Nasal swabs can be used to identify the virus at this stage. Even though the viral load might be minimal, these people are contagious. The RT-PCR result for RNA of virus may be valuable to anticipate the viral burden and the ensuing infectivity and clinical course.

The infection spreads and relocates through the respiratory system ahead the conducting airway, and much strong and healthy innate immune reactions are activated. Nasal swabs or sputum should reveal the infection (SARS-CoV-2) just as early indicators of the innate immune response. COVID-19 is now causing clinical signs and symptoms. The amount of CXCL10 (or another innate response cytokine) might be prescient of the resulting clinical outcome. Viral infected epithelial cells are important source of beta and lambda interferons. CXCL10 is an interferon responsive gene with a high signal-to-noise ratio in the response of alveolar type II cells SARS-CoV and influenza. CXCL10 has likewise been accounted for to be helpful as illness marker in severe acute respiratory syndrome.

Phase III: Hypoxia, ground glass infiltrates, and development to acute respiratory distress syndrome Unluckily, phase 3 of illness will be developed by approximately 20% of the infected patients and will pulmonary infiltrate and a portion of these will progress to extremely serious infection. Now, the virus infects the alveolar type II cells after entering in the gas exchange unit of the lungs. After comparing the type I cells with type II cells, both SARS-CoV and influenza specially infect the type II cells. The result is that a self-reproducing pulmonary toxin is produced by the viral particles which infect type II cells in nearby units. Regions of the lung will probably lose most of their type II cells, and secondary pathway for epithelial recovery will be activated. Generally, type II cells are the forerunner cells for type I cells. This hypothesized series of events have appeared in the murine model of influenza pneumonia. After pathology of SARS and COVID-19, it was found that SARS and COVID-19 diffuse alveolar damage with fibrin rich hyaline membranes and a small number of multinucleated giant cells.

A robust innate and acquired immunity and epithelial regeneration will be needed for the recuperation. The apical cilia present in the respiratory tract and microvilli on type II cells might be essential for facilitating viral entry (Mason, 2020) .

It was found that SARS-CoV in 2003 and MERS-CoV in 2012 were discovered from Chiroptera and Camelus dromedarius sequentially. In this sequence, SARS-CoV-2 which is ninety-six percent identical to SARS-CoV is also supposed to be developed from the bats and spread through creature human contact in Wuhan meat market, Hubei area, China (Mohan and Nambiar, 2020). Although, it had obtained the ability to move from human to human because of mutation change (Rajendran et al., 2020) . In Dec 2019, mature persons in Wuhan, metropolis town of Hubei territory and an utmost transportation centre of China commenced transpiring to nearby medical centre with serious pneumonia of unspecified source. The large number of starting patients possessed a normal exposure to the market where alive animals were sold that was Huanan wholesale seafood market. The monitoring system was initiated, and respiratory samples of sick persons were conveyed to the reference laboratory for aetiologic analysis.

China informed to the WHO about epidemic on 31 st Dec 2019, and the Huanan Sea food market was shut on 1 st Jan 2020. The virus was recognized as a Coronavirus on seventh January. The samples were taken from the atmosphere of Huanan Sea food market and found to be positive after testing, meaning that the virus was developed from that point. A lot of cases started growing speedily, some of which didn't have introduction to the alive animal market, proved to be true that person-to-person spreading was going on. On 11 th Jan 2020, death cases were announced. The epidemic was fuelled by the massive migration of Chinese over the Chinese New Year. People returning from Wuhan had cases in various regions of China and from numerous countries (consistently Thailand, Japan, and South Korea). Spreading of virus to health care persons who were caring for sufferers reported on Jan 20 ,2020. By 23 rd of Jan, Wuhan's eleven million people were put down under lock down with limitations of ingress and egress from the territory. This curfew was quickly extended to several cities in the Hubei area. 

The manifestations of COVID-19 are different with individual person. It might induce not many or no manifestations. Notwithstanding, it can cause serious sickness and might be life threatening. After sickness, it might take 2-14 days for an individual person to induce manifestations. Cold-or influenza like indications generally set in from 2-4 days after COVID-19 and which are generally not severe. Symptoms include Rhinorrhea, watery diarrhoea, pharyngitis, tiredness, dry cough, pyrexia and shortness of breath (Unhale et al., 2020) .

Extra manifestations involve, frailty, tiredness, spewing, loose bowels, variation in taste and scent. The most widely recognized manifestations in hospitalized sufferers are pyrexia (up to ninety percent of sick persons), dry hack (60% to 86%), windedness (53% to 80%), tiredness (thirty-eight %), queasiness/regurgitating or looseness of the bowels (15%-39%), and muscular pain (15%-44%). Patients can additionally give nonclassical manifestations, for example, isolated gastrointestinal side effects. Olfactory or potentially taste defectiveness has been accounted for in sixty-four percent to eighty percent of sufferers. Loss of smell or loss of taste might be the only introducing side effect in around 3% of patients. Intricate with COVID-19 cause vitiated physiology of the cardiac, cerebrum, respiratory, hepatic, renal, and coagulation system. Coronavirus can cause cardiomyopathy, myocarditis, ventricular arrhythmias, and hemodynamic precariousness (Wiersinga et al., 2020).

Since the World Health Organization as of late declared COVID-19 an epidemic on 11 March 

A standard is set for the diagnosis of SARS-CoV2, sample is taken from the respiratory tract (mainly from nasopharynx) and reverse transcription polymerase chain reaction-based SARS-CoV2 RNA diagnosis is done. Nonetheless, the sensitivity of testing changes with timing of testing comparative with subjection. The components which give the false-negative test results are sufficiency of the sample collection method, time from subjection, and source of sample.

The specimen which is taken from lower respiratory tract, are more sensitive than upper respiratory tract for example, bronchoalveolar lavage fluid.

A few serological assays can be helpful in the detection and estimation of reactions to new vaccines. Accessible serological tests contain high throughput enzyme immunoassays and point-of-care tests. Nonetheless, assay production, precision, and viability are changeable.

An orderly survey of nineteen investigations of 2874 sufferers who generally belonged to China (52 years was average age), of whom eighty-eight percent were admitted in hospitals, revealed the normal scope of research facility anomalies appeared in COVID-19, containing raised serum C-reactive protein (elevated in> sixty percent of sufferers), lactate dehydrogenase (elevated in about fifty percent to sixty percent of patients), alanine aminotransferase (increased in about twenty-five percent of patients), and aspartate aminotransferase (roughly thirty-three percent). The albumin protein was found to be less or lower in about 75% of patients. The most well-known haematological anomaly is lymphopenia (total lymphocyte count five percent of sufferers), mild thrombocytopenia (found in around thirty percent of sufferers) and raised Ddimer values (found in 43%-60% of sufferers) were normal. 

It was reported that person-to-person transmission in SARS-CoV-2 disease happens essentially 

Previously, no powerful antiviral treatment or immunization is accessible for coronavirus disease. Notwithstanding, a randomized multicentre controlled clinical trial is in progress to evaluate the efficiency of abidole and wellbeing in sick persons having coronavirus disease.

Antipyretic treatment like paracetamol, are the primary therapy for pyrexia while expectorants, for example, guaifenesin might be utilized for dry cough. Patients which have extreme serious respiratory illness, respiratory misery, hypoxaemia or trauma require the management of quick oxygen treatment (Sohrabi et al., 2020) . Quarantine and supportive care which include oxygen treatment, fluid administration, and antibiotics therapy for secondary bacterial diseases is suggested. Not either is a treatment accessible. Along these lines, the management of the illness has been generally strong and supportive alluding to the ailment seriousness which has been presented by WHO. It was clinically proved that corticosteroid treatment was not supported (Harapana et al., 2020) . The therapy that has been used till now revealed that seventy-five sick persons were treated with already existed antiviral medicaments. The regimen of therapy contained "Bis in die" oral organization of ritonavir 500 mg, lopinavir 500 mg, oseltamivir 75 mg, and the intravenous management of ganciclovir 0·25 g for three to fourteen days. A second record revealed that the broad-spectrum antiviral drug like chloroquine and remdesivir are extremely efficacious in the management of 2019 novel coronavirus disease in vitro. Human patients with a similar history have been treated with a combination of these antiviral medicines. Subsequently, these curative agents can be considered to treat coronavirus disease.

In this way, till further particular curatives become accessible, it is sensible to consider more wide range antivirals that give drug therapy choices to coronavirus illness which include Ritonavir or Lopinavir, peptide (EK1), RNA synthesis inhibitors, Neuraminidase inhibitors. It is completely understood that extra study is essentially required to find out new chemotherapeutic medicines for the treatment of coronavirus diseases (Rothan et al., 2020).

Proof has indicated that plasma from recuperated sufferers can be a successful therapy for SARS and MERS and can aid lessen the death rate overall. The body induces immune reactions in response to SARS-CoV-2 disease, resulting in production of specific antibodies. Prior to treatment with nonspecific antiviral medications, plasma from recuperated sick persons can be utilized to cure sufferers with serious coronavirus disease (Xie et al., 2020).

Azithromycin is a macrolide antibiotic that has been broadly utilized in patients with persistent pulmonary inflammatory disorders or publicly gained pneumonia because azithromycin has anti-inflammatory effect.

Vitamin C possesses antioxidant effects. It takes a part in decreasing the inflammatory reaction.

After the study it was found that ascorbic acid down-regulates the generation of proinflammatory cytokines. A randomized controlled trial is in progress and in stage 2 to examine the clinical efficacy and safety margin of vitamin C infusion therapy to treat pneumonia occurs in coronavirus illness.

It had been discussed that high amount of the zinc in the inner part of the cell can cause efficaciously weaken replication of various RNA virus, for example, flu and polioviruses.

During a study it was found that zinc-ionophores combined with zinc like pyrithione impeded the reproduction of SARS-CoV in cell cultures.

Montelukast produces anti-inflammatory effects, and it suppresses the oxidative stress. However, now-a-days vaccines are available. The first immunization program began towards the beginning of December 2020 (https://www.who.int/news-room/q-a-detail/coronavirusdisease-(covid-19)-vaccines?). The advancement of an immunization against a specific microbe is a tedious and monotonous procedure. In the current situation, a vaccine as protection from SARS-CoV-2 seems to be only desire to control the epidemic and the vaccine was accessible in around 10 months for the use of community health. 

Local side effects Redness, Inflammation, Pain at injection site.

Pyrexia, Headache, Chills, Vomiting, Loose motions, New or worsening joint pain, Lymphadenopathy, Bell's palsy.

Appendicitis, Myocardial infarction, Cerebrovascular accident, Shoulder injury, Lymphadenopathy on contralateral side. 

ACE2 takes part in the immune and cardiovascular system which is a membrane bound aminopeptidase (Turner et al., 2004) . ACE2 is associated with cardiovascular functions and also participates in the generation of diabetes mellitus and high blood pressure (Table 2) .

Likewise, ACE2 has been recognized as a useful receptor for coronaviruses, incorporating 

Currently procurable proof recommends that the SARS-CoV-2 infection can penetrate the brain 

During this quickly evolving COVID-19 epidemic, pregnant ladies' health must be considered.

It is essential to give medical care required to pregnant ladies. World Health Organization has 

As per RCOG, there is not sufficient information at present to give a relationship between the Coronavirus disease and chance of spontaneous abortion or that the infection has teratogenicity.

The chance of perinatal spreading requires extra investigation as there has been clashing outcomes up to this point. When there is confirmation of maternal coronavirus infection, foetal and respiratory suffering for premature rupture of membranes, utero and premature birth has been described (Akhtara et al., 2020) . Be that as it may, whether the premature birth is because of iatrogenic aetiology or different factors, further research is needed for a decisive result.

Numerous investigations reported symptomless infants, delivered from COVID-19 infected indicates that wearing a N95 mask caused acne, face tingling, and even dermatitis in more than 33% of medical care employees [62] . In the matter of contact dermatitis counteraction, we suggest that use a skin defensive cream habitually, particularly after hand cleaning and before wearing personal protective equipment (Yan et al., 2020) .

In fact, various endocrine glands have ACE2, to be specific thyroid, pancreas, ovary, testis, pituitary and adrenal glands . Despite the fact that one could anticipate endocrine repercussions because of reaction of SARS-CoV-2 with ACE2 present on these glands, there is no clinical or pre-clinical information till now (Pal and Banerjee, 2020 

It is studied that in SARS-CoV-2 infection, just as in different contagious sicknesses, for 

Epidemiological information disclosed the serious sickness rate of coronavirus disease can be as high as twenty percent, and despite the fact that the lungs are the principal parts influenced, the kidney is additionally one of the primary parts influenced in serious sickness 

While most Coronavirus disease have respiratory sickness, a few individuals described gastrointestinal manifestations like loose bowels, spewing, and abdominal discomfort throughout the time of the infection.

Patients with coronavirus disease could have liver damage with increased enzymes detected in blood tests. The portion of liver damage was additionally higher in patients which have serious coronavirus disease.

The skin problems in the coronavirus disease were at the beginning because of the hyperhydration impact of PPE, epidermal barrier breakdown, abrasion, and contact responses, all of them may exasperate an earlier skin sickness. Various skin changes have been reported like skin redness, papules, maceration, and scaling by the wearing of personal protective equipment (PPE). Clinical symptoms contain itching, stinging, and burning. Impact on endocrine system Various endocrine glands have ACE2, to be specific thyroid, pancreas, ovary, testis, pituitary and adrenal glands. Despite the fact that one could anticipate endocrine repercussions because of reaction of SARS-CoV-2 with ACE2 present on these glands, there is no clinical or pre-clinical information till now. There is damage in exocrine pancreas showed as raised serum amylase as well as lipase in seventeen percent and one to two percent of sufferers with serious and non-serious COVID-19 patients, respectively.

In SARS-CoV-2 infection, just as in different contagious sicknesses, for example, flu, varicella, dengue, HIV, MERS-CoV and SARS-CoV, hematological changes can happen. The most widely recognized hematological detection contains lymphocytopenia, neutrophilia, eosinopenia, less frequently thrombocytosis and mild thrombocytopenia.

Coronavirus disease can produce acute kidney infection and is a distinct threat part for death rate. It additionally affects sufferers having chronic kidney disease, renal relocation, and chronic substitution treatments.

The vaccines for COVID-19 have powerful immune response, safe and well-tolerated. But these vaccines have some drawbacks like threat of persisting virulence, especially for immunocompromised persons, reduce immunogenicity and threat of genomic unification; Preexisting immunity to the vector diminished the response. COVID-19 vaccines have some common adverse effects like Redness, Inflammation, Pain at injection site, Pyrexia, Headache, Chills, Vomiting, Loose motions, New or worsening joint pain, Lymphadenopathy, Bell's palsy, Appendicitis, Myocardial infarction, Cerebrovascular accident, Shoulder injury, Lymphadenopathy on contralateral side.

COVID-19 is a more contagious disease. According to the study, COVID-19 is transmitted both asymptomatically and symptomatically. COVID-19 is spread through human-to-human transmission or contact with an infected person. This disease primarily affects the elders and children. Various diagnosis methods are used for the detection, like RT-PCR, serology, imaging, etc. Different preventive measures are used, like PPE, face masks, and hand hygiene is essential. COVID-19 is treated with a variety of antiviral medicines. Vit-D is also helpful in decreasing the risk of illness and enhancing immunity. Vit-C also helps in the treatment of COVID-19. Plasma from recovered patients is used to treat COVID-19 patients. Nowadays, different viral-like particle vaccines, including entire inactivated virus vaccines, viral vector vaccines, live attenuated virus vaccines, subunit vaccines, RNA vaccines, and DNA vaccines, are available for the treatment of COVID-19. This virus produces different life-threatening situations. Coronavirus will spread and cause outbreaks with different mutant strains in the future. This situation is very difficult for everyone. We must find a more powerful means of fighting against this virus. As the current epidemic continues, further study is required regarding COVID-19.

COVID-19 pandemic causing acute kidney injury and impact on patients with chronic kidney disease and renal transplantation

COVID 19: a review outbreak and the critical role of pathology during corona virus disease 2019 (COVID-19) and other viral outbreaks

COVID-19 (SARS-CoV-2) infection in pregnancy: a systematic review

Acute myocarditis associated with novel middle east respiratory syndrome coronavirus

Innovations and development of Covid-19 vaccines: A patent review

Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral

Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study Life Sci

Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review

Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 Infection

Headaches during COVID-19: my clinical case and review of the literature

COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up

Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients

A multidisciplinary review

COVID-19) Infection in Pregnancy|Guidance |RCOG

COVID-19 pandemic and the skin: what should dermatologists know?

Coronavirus disease -2019 COVID-19

Occupational skin disease among healthcare workers during the coronavirus (COVID-19) epidemic

Hematologic parameters in patients with COVID-19 infection

Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells

Spectrum of neurological manifestations in Covid-19: a review

Evidence that vitamin d supplementation could reduce risk of influenza and covid-19 infections and deaths

Clinical characteristics of coronavirus disease 2019 in China

Maternal death due to COVID-19 disease

Coronavirus disease 2019 (COVID-19): a literature review

Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis

First case of 2019 novel coronavirus in the United States

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Rhabdomyolysis as potential late complication associated with COVID-19

COVID vaccines: A step towards ending the pandemic

Mortality of a pregnant patient diagnosed with COVID-19: a case report with clinical, radiological, and histopathological findings

Corona virus: a review of COVID-19

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol

Coronavirus vaccine development: from SARS and MERS to COVID-19

Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues

Highly ACE2 expression in pancreas may cause pancreas damage after SARS-CoV-2 infection. medRxiv preprint

Coronavirus disease 2019 (COVID-19) during pregnancy: a case series

SARS-CoV-2 infection in children

Effects of temperature variation and humidity on the death of COVID-19 in Wuhan

COVID-19 pandemic: a review based on current evidence

Neurologic manifestations of hospitalized patients with coronavirus disease

Pathogenesis of COVID-19 from a cell biology perspective

An Insight into SARS-CoV-2 Pandemic Originated at Wuhan City in Hubei Province of

Smell dysfunction: a biomarker for COVID-19

Coronavirus in pregnancy and delivery: rapid review

The Novel Coronavirus 2019 epidemic and kidneys

A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children

Does SARS-Cov-2 invade the brain? translational lessons from animal models

The pathogenesis of coronavirus disease 2019 (COVID-19): evaluation and prevention

COVID-19 and the endocrine system: exploring the unexplored

Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic

Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Novel coronavirus (COVID-19) outbreak: a review of the current literature

A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency

A literature review on serious pandemic disease: -COVID-19

Migraine in the time of COVID-19

A review of coronavirus disease-2019 (COVID-19)

World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)

The trinity of COVID-19: immunity, inflammation and intervention

COVID-19: review and hematologic impact

ACE2: from vasopeptidase to SARS virus receptor

A review on corona virus (COVID-19)

Dermatologic manifestations of the 1918-1919 influenza pandemic

Covid-19 and the digestive system

Severe COVID-19: a review of recent progress with a look toward the future

Consensus of Chinese experts on protection of skin and mucous membrane barrier for healthcare workers fighting against coronavirus disease 2019

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

COVID-19 pathophysiology: A review

Liver injury in COVID-19: management and challenges

Acute myelitis after SARS-CoV-2 infection: a case report

COVID-19 and the cardiovascular system

Clinical analysis of 10 neonates born to mothers with 2019-nCov pneumonia

The authors are thankful to AlMaarefa University, Riyadh for providing support to do this review article.